Helicobacter Pylori Infection in Patients with End-Stage Renal Disease

Milito G. , Taccone-Gallucci M. , Brancaleone C. . The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int 1985; 28(suppl.): S157–60.

Ala-Kaila K. . Upper gastrointestinal findings in chronic renal failure. Scand J Gastroenterol 1987; 22: 372–6.

Holcombe C. , Omotata B.A. , Eldridge J. , Jones D.M. . Helicobacter pylori, the most common chronic bacterial infection in Africa: a random serological study. Am J Gastroenterol 1992; 87: 28–30.

NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65–9.

Weaver L.I. , Shepherd A.J. , Doherty C.P. , McColl K.E.L. , Williams C.L. . Helicobacter pylori in the faeces? QJM 1999; 92: 361–4.

Mendall M.A. , Goggin P.M. , Molineaux N. . Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339: 896–7.

Tielemans C. , Verhas M. , Glupezynski Y. , Nest J.F. , Deirenre M. , Draiwa M. . Urea breath test screening for Campylobacter pylori infection in uraemic patients. In: Megraud F. , Lamouliatte E. eds. Gastroduodenal pathology and Campylobacter pylori. Amsterdam Excerpta Medica, 1989; 541–3.

Offerhaus G.J.A. , Kreuning J. , Valentijn R.M. . Campylobacter pylori: prevalence and significance in patients with chronic renal failure. Clin Nephrol 1989; 32: 239–41.

Conz P. , Chiaramonte S. , Ronco C. , Feriani M. , La Greca G. . Campylobacter pylori in uremic dialyzed patients (Letter). Nephron 1989; 53: 90.

Deveniotis V. , Koliouskas D. , Kalckou H. . Campylobacter pylori in severely uremic hemodialyzed and successfully transplanted patients. Abstracts. XIth International Congress of Nephrology, Tokyo 1990: 138A.

Di Giorgio P. , Rivellini G. , D'Alessio L. , Di Benedetto A. , De Luca B. . The influence of high blood levels of urea on the presence of Campylobacter pylori in the stomach: a clinical study. Ital J Gastroenterol 1990; 22: 64–5.

Shousha S. , Arnaout A.H. , Abbas S.H. , Parkins R.A. . Antral Helicobacter pylori in patients with chronic renal failure. J Clin Pathol 1990; 43: 397–9.

Davenport A. , Shallcross T.M. , Crabtree J.E. , Davison A.M. , Will E.J. , Heatley R.V. . Prevalence of Helicobacter pylori in patients with end-stage renal failure and renal transplant recipients. Nephron 1991; 59: 597–601.

Loffeld RJLF , Peltenburg H.G. , Qever H. , Stobbering E. . Prevalence of Helicobacter pylori antibodies in patients on chronic intermittent haemodialysis. Nephron 1991; 59: 250–3.

Rowe P.A. , El Nujumi A. , Williams C. , Dahill S. , Briggs J.D. , McColl K.E.L. . The diagnosis of Helicobacter pylori infection in uremic patients. Am J Kidney Dis 1992; 20: 574–9.

Gladziwa U. , Haase C. , Handt S. . Prevalence of Helicobacter pylori in patients with chronic renal failure. Nephrol Dial Transplant 1993; 8: 301–6.

Teenan R.P. , Burgayne M. , Brown I.L. , Murray W.R. . Helicobacter pylori in renal transplant recipients. Transplantation 1993; 56: 100–3.

De Vecchi A. , Quattrini M. , Boni F. . Epidemiology of Helicobacter pylori in dialysis patients (Letter). Perit Dial Int 1995; 15: 178–9.

Jaspersen D. , Fassbinder W. , Heinkele P. . Significantly lower prevalence of Helicobacter pylori in uremic patients than in patients with normal function. J Gastroenterol 1995; 30: 585–8.

Luzza F. , Imeneo M. , Maletta M. . Helicobacter pylori specific lgG in chronic haemodialysis patients: relationship of hypergastrinemia to positive serology. Nephrol Dial Transplant 1996; 11: 120–4.

Hruby Z. , Myszka-Bijak K. , Goscinian G. . Helicobacter pylori in kidney allograft recipients: high prevalence of colonization and low incidence of active inflammatory lesions. Nephron 1997; 75: 25–9.

Moustafa F.E. , Khalil A. , Wahab M.A. , Sobh M.A. . Helicobacter pylori and uremic gastritis: a histopathologic study and a correlation with endoscopic and bacteriologic findings. Am J Nephrol 1997; 17: 165–71.

Tamura H. , Tokushima H. , Murakawa M. . Eradication of Helicobacter pylori in patients with end-stage renal disease under dialysis treatment. Am J Kidney Dis 1997; 29: 86–90.

Ozgur O. , Boyacioglu S. , Ozdogan M. , Gur G. , Telatar H. , Haberal M. . Helicobacter pylori infection in haemodialysis patients and renal transplant recipients. Nephrol Dial Transplant 1997; 12: 289–91.

Antoniou S. , Dimitriadis A. , Kliridou M. , Pavlitou K. , Batzili H. , Malaka E. . Prevalence of Helicobacter pylori antibodies in CAPD patients (Letter). Nephron 1997; 75: 358–9.

Munoz de Bustillo E. , Sanchez Tomero J.A. , Sanz J.C. . Eradication and follow-up of Helicobacter pylori infection in hemodialysis patients. Nephron 1998; 79: 55–60.

D'Elia F. , Tarantino G. , Brusasco S. . La malattia gastroduodenale e l'infezione da Helicobacter pylori in pazienti uremici in emodialisi periodica ed in portatori di trapianto di rene. Giorn It Nefrol 1998; 15: 185–90.

Fabrizi F. , Martin P. , Dixit V. . Epidemiology of Helicobacter pylori in chronic haemodialysis patients using the new RIBA^TM H. pylori SIA. Nephrol Dial Transplant 1999; 14: 1929–33.

Bizzozero G. . Ueber die schlauchfoermigen drusen des magendarmkanals und die bezziehungen ihres epithels zu dem oberfachenepithel der schleimhaut. Arch f Mikr Anat 1893; 42: 82–152.

Salomon H. . Ueber das spirillum des saugetiermagens und sein verhalten zu den belegzellen. Zentralbl Bakteriol Mikrobiol Hyg 1896; 19: 433–42.

Kreinitz W. . Ueber das aufireten von spirochaeten verschiedener form im mageninhalt bei carcinoma ventriculi. Dtsch Med Woch-Enschr 1921; 92: 54–75.

Rosenow E.C. , Sanford A.H. . The bacteriology of ulcer of the stomach and duodenum in man. J lnfect Dis 1915; 17: 219–26.

Luger A. , Neuberger H. . Ueber spirochatenbefunde im magensaft und deren diagnostitsche bedeutung fur das carcinoma ventriculi. Ztschrfklin Med 1921; 92: 54–75.

Palmer E.D. . Investigation of the gastric mucosa spirochetes of the human. Am J Dig Dis 1940; 7: 443–5.

Steer H.W. , Cohn-Jones D.G. . Mucosal changes in gastric ulceration and their response to carbenoxolone sodium. Gut 1975; 16: 590–7.

Warren I.R. . Unidentified curved bacillus on gastric epithelium in active chronic gastritis (Letter). Lancet 1983; 1: 1273.

Marshall B. . Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273–5.

Marshall B.J. , Armstrong J.A. , McGechie D.B. , Glancy R.J. . Attempt to fulfill Koch's postulates for pyloric Campylobacter Med J Aust 1985; 142: 436–9.

Validation of publication of new names and new combinations previously effectively published outside the IJSB. Int J Syst Bacteriol 1985; 85: 223–5.

Buck G.E. , Gourley W.K. , Lee W.K. , Subramanyam K. , Latimer J.M. , DiNuzzo A.R. . Relation of Campylobacter pyloridis to gastritis and peptic ulcer. J Infect Dis 1986; 153: 664–9.

Dooley C.P. , Cohen H. . The clinical significance of Campylobacter pylori. Ann Intern Med 1988; 108: 70–9.

Goodwin C.S. , Armstrong J.A. , Childers I. . Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen nov. As Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively. Int J Syst Bacteriol 1989; 39: 397–405.

Blaser M.J. . The bacteria behind ulcers. Sci Am 1996; 274: 104–7.

Lee J.L. , Q'Morain C. . Consensus or confusion: a review of existing national guidelines on Helicobacter pylori-related disease. Eur J Gastroenterol Hepatol 1997; 9: 527–31.

Gasbarrini A. , Franceschi F. , Gasbarrini G. . Extraintestinal pathology associated with Helicobacter infection. Eur J Gastroenterol Hepatol 1997; 9: 231–3.

Van Doom U. , Figueiredo C. , Sanna R. . Clinical relevance of the CagA, VacA, and IceA status of Helicobacter pylori. Gastroenterology 1998; 115: 58–66.

Cutler A.F. , Havstad S. , Ma C.K. , Blaser M.J. , Perez-Perez G.I. , Schubert I.T. . Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995; 109: 136–41.

Xiang Z.Y. , Censini S. , Bayeli P.F. . Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995, 63: 94–8.

Censini S. , Lange C. , Xiang Z. . Cag, a pathogenicity island of Helicobacter pylori, encodes type-I specific and disease-associated virulence factors. Proc NatI Acad Sci USA 1996, 93: 14648–53.

Salmond G.P.C. . Secretion of extracellular virulence factors by plant pathogenic bacteria. Ann Rev Phytopathol 1994; 32: 181–200.

Blaser M.J. , Perez-Perez G.I. , Kleanthous H. . Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111–5.

Beales I.L. , Crabtree J.E. , Scunes D. , Covacci A. , Calam J. . Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996, 8: 645–9.

Van Doom U. , Quint W.G.W. , Schneeberger P.M. , Tytgat G.N.J. , De Boer W.A. . Association between VacA and CagA status of Helicobacter pylori and the efficacy of a 1-day quadruple therapy. Lancet 1997; 350: 71–2.

Marshall B.J. , Warren J.R. , Francis G.J. . Rapid urease test in the management of Campylobacter pylori associated gastritis. Am J Gastroenterol 1987, 82: 200–10.

Johnston B.J. , Ali M.H. , Haines K. , Reed P.I. . Campylobacter-like organisms in the duodenal mucosa and the effect of ulcer treatment on their presence. Gut 1985; 26: 579–80.

Gilman R.H. , Leon-Barua R. , Koch J. . Rapid identification of pyloric Campylobacter in Peruvians with gastritis. Dig Dis Sci 1986; 31: 1089–95.

Walters L.L. , Budin R.E. , Paull G. . Acridine-orange to identify Campylobacter pyloridis in formalin fixed, paraffin-embedded gastric biopsies (Letter). Lancet 1986; 1: 42.

Pinkard K.J. , Harrison B. , Capstick J.A. , Medley G. , Lambert J.R. . Detection of Campylobacter pyloridis in gastric mucosa by phase contrast microscopy. J Clin Pathol 1986; 39: 112–3.

Dixit V. , Sra K. , Yee H.F. . A new serological test, RIBA^TM H. pylori SIA, that improves the detection of H. pylori. Gastroenterology 1997; 112: Al04.

Dixit V. , Bettis K. , Yee H.F. . Prevalence of specific ulcer-associated H. pylori antibodies in volunteer and paid blood donors using the new RIBA^TM H. pylori SIA. Gastroenterology 1997; 112: A104.

Hazell S.L. , Lee A. . Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet 1986; 2: 15.

Korman M.G. , Layer M.C. , Hanky J. . Hypergastrinaemia in chronic renal failure. Br Med J 1972; 272: 209–10.

Chittajallu R.S. , Neithercut W.D. , Ardill J.E.S. . H. pylori related hypergastrinaemia is not due to elevated antral surface pH: studies with antral alkalinization. Scand J Gastroenterol 1994; 89: S116–28.

EI-Omar E. , Penman I. , Dorrian C.A. . Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993; 34: 1060–5.

Levi S. , Beradshall K. , Haddad G. . Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989; 1: 1167–8.

Tamura H. , Tokushima H. , Murawaka M. . Influences of Helicobacter pylori on serum pepsinogen concentrations in dialysis patients. Nephrol Dial Transplant 1999; 14: 113–7.

Chittajallu R.S. , Dorrian C.A. , Ardill J.E.S. , McColl K.E.L. . Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol 1992; 27: 20–4.

Raufman J.P. , Sutliff V.E. , Kasbekar D.K. , Jensen R.I. , Gardner J.D. . Pepsinogen secretion from dispersed cells from guinea pig stomach. Am J Physiol 1984; 247: G95–G104.

Kodoi A. , Yoshihara M. , Sumii K. , Haruma K. , Kajiyama G. . Serum pepsinogen in screening for gastric cancer. J Gastroenterol 1995; 30: 452–60.

Maisonneuve P. , Agodoa L. , Gellert R. . Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999 354: 93–9.

Berstad A. , Alexander B. , Weber G. , Serck-Hanssen A. , Holland S. , Hirschowitz B.I. . Antacids reduce Campylobacter pylori colonisation without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes. Gastroenterology 1988; 95: 619–24.

Simenhoff M.L. , Sankonen J.J. , Burke J.F. , Wasson L.G. , Schaedler R.W. , Gordon S.J. . Bacterial population of the small intestine in uraemia. Nephron 1978; 22: 63–7.

Sitas F. , Forman D. , Yarnell J.W.G. . Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut 1991; 32: 25–8.

Boran M. , Cetis S. . Helicobacter pylori and Giardia lamblia infections in hemodialysis patients (Letter). Nephrol Dial Transplant 1999; 14: 1803–4.

Oberhuber G. , Kastner N. , Stolte M. . Giardiasis: a histologic analysis of 567 cases. Scand J Gastroenterol 1997; 32: 48–51.

Kao C.H. , Hsu Y.H. , Wang S.J. . Delayed gastric emptying and Helicobacter pylori infection in patients with chronic renal failure. EurJ Nud Med 1995; 22: 1282–5.

Wegener M. , Borsch G. , Schaffstein J. , Shulz-Flake C. , Mai U. , Leverkus F. . Are dyspeptic symptoms in patients with Campylobacter pylori - associated type B gastritis linked to delayed gastric emptying ? Am J Gastroenterol 1988; 83: 737–40.

Axon I. . Drug regimens. In: Northfield I.C. , Mendall M. , Goggin P.M. eds. Helicobacter pylori infection. Dordrecht, The Netherlands: Kluwer Academic, 1993; 149–57.

Axon A.T.R. . The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: (suppl 201) S16–23.

Burette A. , Glupczynski Y. , De Prez C. . Evaluation of various multi-drug eradication regimens for Helicobacter pylori. EurJ Gastroenterol Hepatol 1992; 4: 817–23.

Tokushima H. , Tamura H. , Murakawa M. . Eradication of Helicobacter pylori restores elevation of serum gastrin concentrations in patients with end-stage renal disease. Intern Med 1998; 37: 435–9.